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Abstract
Background: Accelerometry data are frequently analyzed without considering whether moderate-to-vigorous
physical activities (MVPA) were performed in bouts of >10 minutes as defined in most physical activity guidelines.
We aimed i) to quantify MVPA by using different commonly-applied physical activity guidelines, ii) to investigate the
effect of bouts versus non-bouts analysis, and iii) to propose and validate a MVPA non-bouts cut-point to classify (in-)
active subjects.
Methods: Healthy subjects (n=110;62±6yrs) and patients with Chronic Obstructive Pulmonary Disease (COPD)
(n=113;62±5yrs) wore an activity monitor for 7 days. Three Metabolic Equivalent of Task (MET) cut-offs and one
individual target (50% VO2 reserve) were used to define MVPA. First, all minutes of MVPA were summed up (NON-
BOUTS). Secondly, only minutes performed in bouts of >10 minutes continuous activity were counted (BOUTS).
Receiver operating characteristic (ROC) curve analyses were used to propose and (cross-) validate new MVPA non-
bout cut-points based on the criterion of 30 minutes MVPA per day (BOUTS). Likelihood ratios (sensitivity/[1-
specificity]) were used to express the association between the proposed MVPA non-bout target and the MVPA bout
target of 30 min*day-1.
Results: MVPA was variable across physical activity guidelines with lowest values for age-specific cut-offs. Selecting
a METs cut-point corresponding to 50% VO2 reserve revealed no differences in MVPA between groups. MVPA’s
analyzed in BOUTS in healthy subjects were 2 to 4 fold lower than NON-BOUTS analyses and this was even 3 to 12
fold lower in COPD. The MVPA non-bouts cut-point of 80 min*day-1 using a 3 METs MVPA threshold delivered
positive likelihood ratios of 5.1[1.5-19.6] (healthy subjects) and 2.3[1.6-3.3] (COPD).
Conclusion: MVPA varies upon the selected physical activity guideline/targets and bouts versus non-bouts analysis.
Accelerometry measured MVPA non-bouts target of 80 min*day-1, using a 3 METs MVPA threshold, is associated to
the commonly-used MVPA bout target of 30 min*day-1.
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Introduction
The increasing burden of a physically inactive lifestyle has
become a worldwide public health problem since it is directly
related to morbidity and mortality and therefore does increase
the health care costs [1]. For example, it is well established that
physical inactivity is linked to a higher risk of developing type II
diabetes [2], cancer [3], cardiovascular disease [4] and chronic
obstructive pulmonary disease (COPD)[5]. Physical activity
guidelines propose that the amount of time spent in moderate
to vigorous physical activities (MVPA) to maintain health should
be sufficiently high. The target of at least 30 minutes of MVPA
per day, in bouts of at least 10 minutes, during at least 5 days
of the week is proposed to distinguish active from inactive
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subjects [6,7]. A recent meta-analysis showed that 30 minutes
of MVPA (bouts) per day during at least 5 days per week, as
assessed by a self-completed questionnaire or an interview,
was associated with a reduction in 19% of mortality risk [8].
Daily physical activity level (PAL; ratio of total energy
expenditure over resting energy expenditure) is another
important physical activity outcome which can be used to
classify subjects as either active or inactive. It seems likely that
the achievement of 1.7 PAL is needed to prevent the transition
to overweight or obesity [9], one of the first and important
consequences of a physically inactive lifestyle. The daily
targets of ≥ 30 minutes of MVPA (bouts) and 1.7 PAL are
commonly used and are embedded in two official physical
activity recommendations by the World Health Organization
[10,11].
The definition of MVPA is usually expressed in Metabolic
Equivalents of Task (METs), but the absolute cut-points used
vary between different guidelines. The current physical activity
recommendation from the American College of Sports
Medicine (ACSM) and the American Heart Association (AHA)
(2007) defined moderate intense physical activity as ≥ 3 METs
for all ages [6]. Because exercise capacity decreases with age,
the ACSM/AHA recommendation for older adults can be
prescribed at a relative MVPA cut-point, i.e. 50% of the
subject’s oxygen uptake (VO2) reserve, in subjects older than
65 years or those with chronic diseases [7]. The ACSM
Position Stand (2011) proposed cut-offs based on the age of
people, rendering a threshold of 4.0 METs for people up to 65
years and 3.2 for subjects aged 65 years and older [12]. The
current ACSM/AHA physical activity guidelines state that the 30
minute goal should be achieved in bouts of at least 10 minutes
which complicates the assessment. The development of
activity monitors makes accurate assessment (e.g. MVPA) of
daily physical activity levels accessible. Since activity
monitoring is increasingly being used and its data-analysis is
frequently done without bouts, it would be worthwhile to
propose a non-bout MVPA cut-point.
Physical (in-) activity is also an important feature in chronic
disease populations, such as patients with COPD. It is very
well established that MVPA is significantly reduced in patients
with COPD compared to a healthy control group [13]. A recent
cohort study showed that a PAL > 1.7, as assessed by an
activity monitor, was the strongest independent predictor of
survival in patients with COPD [14]. Although PAL levels may
have important predictive power, they cannot be easily
translated into physical activity advice. Therefore, the impact of
using different physical activity guidelines and data analysis
((non-)bouts) along with the validation of the “new” proposed
MVPA non-bout cut-point is important in patient populations
with chronic disease, such as COPD.
In a sample of healthy subjects and patients with COPD we
aimed (i) to investigate to what extent the use of commonly-
applied physical activity guidelines and targets on MVPA
provide different results, (ii) to investigate the effect of bouts
versus non-bouts analysis on MVPA (iii) to propose and
(cross-) validate a non-bout MVPA cut-point equivalent to the
commonly-used 30 minutes (bouts) criterion and to validate this
proposed MVPA non-bout cut-point in healthy subjects and in
patients with COPD.
Materials and Methods
Ethics Statement
The protocol was approved by the Medical Ethical Board of
the University Hospitals Leuven (Leuven, Belgium), number
B32220096387 and B322220095599. All subjects provided
written informed consent.
Study participants
In this retrospective post-hoc cross-sectional study, subjects
with COPD or without COPD ((never-)smokers) were included
from two clinical trials (physical activity counseling study
(NCT00948623) (i.e. adding a physical activity counseling
program during pulmonary rehabilition in patients with
moderate to very severe COPD, randomized controlled trial)
and a case-control study of physical activity and comorbidities
in mild to moderate COPD (NCT01314807) (patients with mild
to moderate COPD and (never-)smokers without COPD) were
included. The results of the physical activity levels and its
association with clinical characteristics in the latter study have
been published elsewhere [15]. Only baseline data from both
trials were used in the present study. COPD was defined by
post bronchodilator spirometry (ratio of forced expiratory
volume in 1s (FEV1) over forced vital capacity (FEV1/FVC) <
0.70). The modified Medical Research Council (mMRC)
dyspnea scale rates the type and magnitude of dyspnea
according to five grades (from mMRC 0 to mMRC 4) of
increasing severity [16]. Symptoms of dyspnea (mMRC scores)
together with GOLD stages (spirometry) and/or exacerbation
history were used to classify patients into the appropriate group
(ranging from group A (low risk, less symptoms) to group D
(high risk, more symptoms)) according to the revised GOLD
classification [17]. . They were clinically stable and free of
exacerbations for at least 4 weeks prior to the study. Subjects
were excluded if they had orthopedic and/or musculoskeletal
problems which would interfere with their movement patterns
(e.g. arthritis).
Study Procedures
All participants performed post-bronchodilator spirometry,
physical exercise testing and assessment of daily physical
activity. Spirometry was performed with standardized
equipment and according to American Thoracic Society and
European Respiratory Society guidelines [18]. FEV1 and FVC
are given as absolute values and expressed as percentages of
the predicted reference values [19]. Functional exercise
capacity was determined by six minute walking distance
(6MWD) [20]. Values were related to previously published
reference values for the healthy Belgian population [21]. A
symptom-limited incremental cycle ergometer test according to
the ATS/ACCP statement on cardiopulmonary exercise testing
[22], was used to assess the maximal exercise capacity (peak
VO2) and the VO2 reserve (i.e. peak VO2 – resting VO2). The
Data Analysis of Moderate Physical Activity
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values of peak oxygen consumption were related to previously
described reference values [23].
Subjects were instructed to wear a multisensor physical
activity monitor (SenseWear Pro 2 Armband, Bodymedia,
Pittsburgh, PA) for 7 consecutive days. Subjects from the
physical activity counseling study were asked to wear the
device during waking hours while subjects in the comorbidities
study wore the activity monitor for 24 hours (except showering/
bathing activities). This light weight (80 g) device is worn on the
back of the upper right arm at the level of the triceps. It
assesses accelerations in two planes using a bi-axial
accelerometer. Furthermore skin temperature, near body
temperature, heat flux and galvanic skin resistance are
assessed and stored minute-by-minute for further analysis.
Metabolic Equivalents of Task (METs) estimates from the
SenseWear Pro 2 Armband were available through proprietary
algorithms and equations by the manufacturer. METs data
were downloaded in one minute bins for further analysis. For
each minute of assessment, absolute or relative METs cut
points were used to define MVPA, according to commonly-
applied physical activity recommendations (see table 1). METs
values were converted to kilocalories to calculate total energy
expenditure (TEE) estimates [24]. and were calculated as
follows: TEE (kcal) = measured EE (with the SenseWear during
wearing time) + predicted EE (based on resting energy
expenditure (REE) during non-wearing time). Total energy
expenditure estimates of this activity monitor have recently
been validated against the gold-standard of doubly labeled
water and indirect calorimetry in healthy adults [25] and in
patients with COPD [26,27]. REE was calculated by gender-
specific Harrison and Benedict prediction equations [28]. PAL
was calculated by dividing daily TEE by resting energy
expenditure. The subjects with activity monitoring during the
whole day (24 hours); REE was calculated as the whole-night
sleeping energy expenditure as measured with the SenseWear
Pro 2 Armband [29]. PAL was calculated by dividing TEE by
REE. Daily targets of ≥ 1.7 PAL and ≥ 30 minutes (bouts) of
MVPA (≥ 3 METs) were used to classify subjects as physically
active. A bout was defined as a period of at least 10
consecutive minutes above the recommended (MVPA) METs
cut-point. A valid assessment was defined as a measurement
of at least 5 days (weekend days + at least 3 weekdays) for at
least 12 hours per day [30,31].
Statistical analysis
Normal distribution was tested for all variables by a Shapiro-
Wilk test [32]. Continuous variables were expressed as means
with standard deviations (normal distribution) or as medians
with interquartile ranges (skewed distribution). Categorical
variables were expressed as proportions and testing between
groups was done by a chi-square test. Comparisons between
healthy subjects and patients with COPD were performed by
either a parametric (unpaired t-test) or a non-parametric test
(Wilcoxon-Mann-Whitney test). Comparisons in MVPA (skewed
distribution) among different physical activity guidelines were
tested by a Kruskal Wallis test (with Dunn’s post hoc testing).
Linear regression analysis was performed to calculate MVPA
(bouts) that corresponds to 1.7 PAL. The “split sample”
approach was used to develop and cross-validate new MVPA
non-bout cut-points [33]. We randomly divided our healthy
population sample (n=110) in the 2:1 ratio and used the larger
portion to develop new MVPA non-bout cut-points (calibration
sample, n=73) and the remainder to cross-validate its
performance (cross-validation sample, n=37). First, receiver
operating characteristic (ROC) curve analyses were used to
determine new MVPA non-bout cut-points based on the
criterion of 30 minutes MVPA (bouts) (ACSM/AHA) (< 30
minutes MVPA per day; inactive, ≥ 30 minutes MVPA per day;
active). ROC analyses identified the cut-points at which
sensitivity and specificity were both maximized. Essentially, the
challenge is to determine a cut-point that accurately captures
“physical activity” (sensitivity) without capturing “inactivity”
(specificity). The area under the ROC curve (AUC) is a
measure of the accuracy of the cut-points. ROC AUC values of
≥ 0.90 are considered excellent, 0.80-0.89 good, 0.70-0.79 fair
and <0.70 poor [34]. The new MVPA non-bout cut-points were
subsequently confirmed using linear regression analysis.
Secondly, ROC curve analyses were used to compare
sensitivity and specificity for the new proposed MVPA non-bout
cut-points against the criterion of 30 minutes MVPA (bouts)
(ACSM/AHA), in both the healthy cross-validation sample
(n=37) and in the sample of patients with COPD (n=113).
Likelihood ratios (sensitivity/[1-specificity]) were calculated as a
summarizing diagnostic accuracy statistic [35]. It expresses
how many times more likely active subjects (≥ 30 minutes
MVPA per day (BOUTS)) are to be classified as active
according to the new MVPA non-bout target compared to
inactive subjects (< 30 minutes MVPA per day (BOUTS)). A
Table 1. Metabolic Equivalent of Tasks (METs) cut-points according to different physical activity recommendation.
PA recommendation  METs cut-point to define (MVPA)
ACSM/AHA ≥3.0 METs (for all ages)
ACSM/AHAO ≥3.0 METs (≤65 years) ≥50% VO2 reserve (METs) (>65 years)
50% VO2 reserve Relative METs cut point corresponding to 50% VO2 reserve for each subject
ACSM 2011 ≥4.0 METs (≤65 years) ≥3.2 METs (>65 years)
ACSM/AHA= current American College of Sports Medicine and American Heart Association recommendation (2007); ACSM/AHAo= American College of Sports Medicine
recommendation for older adults (2007); 50% VO2 reserve= individual cut-point corresponding to 50% of oxygen uptake reserve; ACSM 2011: age-dependent cut-points
from ACSM Position Stand 2011. MVPA= time spent in moderate to vigorous physical activities.
doi: 10.1371/journal.pone.0084365.t001
Data Analysis of Moderate Physical Activity
PLOS ONE | www.plosone.org 3 December 2013 | Volume 8 | Issue 12 | e84365
likelihood ratio greater than 1 indicates that the new MVPA
non-bout target is associated with the standard activity target (≥
30 minutes MVPA per day (BOUTS)). The further likelihood
ratios are from 1 the stronger the evidence for the presence of
an active lifestyle (based on the ≥ 30 minutes MVPA per day
(BOUTS) target). Likelihood ratios above 10 are considered to
provide strong evidence to rule in diagnoses in most
circumstances. Data of the SenseWear Pro 2 Armband were
downloaded with SenseWear Professional software 6.0. All
statistical analyses were performed with SAS (version 9.3).
Results
Two hundred fifty-three subjects were included in the present
study; 110 subjects without COPD (comorbidities study) and
113 subjects with COPD (physical activity counseling study
(n=55) and comorbidities study (n=58). Thirty subjects were
excluded from the analysis (no valid physical activity
assessment (n=23), musculoskeletal problems (n=2), cancer
(n=2), rheumatoid arthritis (n=2), not motivated to participate
(n=1). A general overview of the subjects’ characteristics
(n=223) is provided in table 2. Healthy subjects and patients
with COPD did not differ statistically significant for age, sex and
BMI. Lung function, exercise capacity (6MWD, Wmax and peak
VO2) and physical activity (steps and PAL) were significantly
lower in patients with COPD (p<0.0001). A wide range of
patients with COPD was recruited; FEV1 ranged from 0.6 L to
3.87 L, peak VO2 from 1.7 METs to 12.3 METs. The majority of
patients with COPD were classified as quadrant A (50%) or
quadrant D (42%).
Analyzing MVPA with or without bouts of at least 10 minutes,
revealed generally lower activity levels in patients with COPD
compared to healthy controls (p<0.001, table 3). No differences
in MVPA were found between COPD and healthy subjects
when using a relative cut-point of 50% VO2 reserve (table 3).
Using ACSM 2011 cut points resulted in significantly less
minutes in MVPA in both healthy subjects and in patients with
COPD (p<0.001, Figure 1A and 1B). MVPA was significantly
lower in ACSM/AHA(O) guidelines compared to 50% VO2
reserve in patients with COPD (p<0.001, Figure 1A and 1B)
but not in healthy subjects. The median time spent in MVPA
was 2 to 4 fold lower in healthy subjects when analyzing in
bouts compared to non-bouts in all classifications (table 3).
This reduction in MVPA when using bouts was even more
pronounced in patients with COPD (3 to 12 fold lower),
especially for the ACSM 2011 cut points (table 3).
A minority of healthy subjects and patients with COPD were
classified as physically active according to the 1.7 PAL target
(37% and 26%, respectively). In the healthy subjects, daily PAL
of 1.7 corresponds to 57 minutes MVPA per day(95% CI, 0 to
135 minutes) and 122 minutes MVPA per day (95% CI, 18 to
227 minutes), bouts and non-bouts respectively, with ACSM/
AHA.
Table 4 presents how many minutes in non-bouts are
required to meet the 30 minutes MVPA bouts criteria for
several cut-points in the calibration-sample. As the AUC was
highest for the ACSM/AHA cut-point (80 minutes MVPA per
day using a 3 METs MVPA threshold), this was taken forward
for (cross-) validation in healthy subjects and in patients with
COPD. Linear regression analysis confirmed the ROC analysis
Table 2. Overview of the subject’s characteristics.
Variable Healthy subjects (n=110)  Patients with COPD (n=113)
Age 62 ± 6 62 ± 5
Sex (%men) 65 75
BMI 26.2 ± 3.9 26.1 ± 5.4
(Ex-)smokers, n (%)) 52 (47) 58 (53)
FEV1 (L) 3.20 ± 0.76 1.91 ± 0.87*
FEV1 (%pred) 111 ± 18 65 ± 27*
FVC (L) 4.13 ± 0.94 3.62 ± 0.98*
FVC (%pred) 115 ± 17 100 ± 22*
FEV1/FVC (%) 77 ± 4 51 ± 14*
mMRC score 0/1/2/3/4 (n) 77/33/0/0/0 30/34/35/7/7*
Group A/B/C/D (n) N/A 56/0/9/48
6MWD (m) 642 ± 82 516 ± 133*
6MWD (%pred) 97 ± 11 78 ± 19*
Wmax (W) 173 ± 50 109 ± 55*
Wmax (%pred) 117 ± 36 70 ± 32*
METsmax 8.30 ± 2.26 6.01 ± 2.2*
Steps (per day) 9950 [7235-11918] 5725 [3002-8352]*
PAL (TEE*REE-1) 1.64 [1.52-1.76] 1.50 [1.28-1.71]*
Wearing time (hours*day-1) 23.08 ± 1.35 16.87 ± 4.48*
Data are expressed as means ± standard deviation or medians [interquartile range]. BMI= Body Mass Index; FEV1= Forced expired volume in the first second; FVC= Forced
Vital Capacity; mMRC= modified Medical Research Council; 6MWD= six-minute walking distance; Wmax= Maximal workload; METsmax= Maximal Metabolic Equivalent of
Tasks; PAL= Physical Activity Level; TEE= Total Energy Expenditure; REE= Resting Energy Expenditure; N/A= not applicable *p<0.05 COPD versus healthy subjects.
doi: 10.1371/journal.pone.0084365.t002
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regarding the 80 minutes MVPA per day cut-point (30 minutes
MVPA bouts is equivalent to 87 minutes MVPA per day (95%
CI, 71 to 103 minutes MVPA per day)).
Validation of the proposed cut-points
Sensitivity and specificity percentages for this new MVPA
non-bouts cut-point (80 min*day-1) in the healthy cross-
validation sample of 37 subjects (age; 62±6 y, BMI; 25.8±4.1,
Table 3. Daily time spent in moderate to vigorous intense physical activities (MVPA) in healthy adults and patients with
COPD, analyzed with and without bouts of at least 10 minutes.
PA recommendation  MVPA without bouts (min*day-1) MVPA bouts (min*day-1)
 Healthy (n=110) COPD (n=113) Healthy (n=110) COPD (n=113)
ACSM/AHA 106 [70-151] 49 [26 - 99]* 39 [21-75] 13 [2 - 35]*
ACSM/AHAO 123 [74-155] 68 [36 - 135]* 42 [21-75] 16 [3 - 46]*
50% VO2 reserve 120 [76-180] 122 [51 - 202] 47 [19-79] 40 [11 - 87]
ACSM 2011 52 [30-88] 25 [8-52]* 18 [4-35] 3 [0-15]*
All data are expressed as medians [interquartile range]. PA; physical activity, ACSM/AHA= current American College of Sports Medicine and American Heart Association
recommendation (2007) [7]; ACSM/AHAo= American College of Sports Medicine recommendation for older adults (2007) [6]; 50% VO2 reserve = individual cut-point
corresponding to 50% of oxygen uptake reserve; ACSM 2011: age-dependent cut-points from ACSM Position Stand 2011 [12]. *p<0.001 COPD versus healthy subjects.
doi: 10.1371/journal.pone.0084365.t003
Figure 1.  MVPA without (fig.1A) and with bouts (fig.1B) of at least 10 minutes according to different physical activity
guidelines.  ACSM/AHA= current American College of Sports Medicine and American Heart Association recommendation;
ACSM/AHAo= American College of Sports Medicine recommendation for older adults; 50% VO2 reserve= individual cut-point
corresponding to 50% of oxygen uptake reserve; ACSM 2011: age-dependent cut-points from the ACSM Position Stand 2011.
doi: 10.1371/journal.pone.0084365.g001
Table 4. Development of new MVPA non-bouts cut-points in the healthy calibration sample (n=73).
30 minutes MVPA (bouts) per day MVPA non-bout cut points (min*day-1) Sensitivity % [95% CI] Specificity % [95 % CI] AUC
ACSM/AHA 80 83 85 0.89
  (58 to 96) (73 to 93) (0.81 to 0.98)
ACSM/AHAO 93 78 40 0.54
  (56 to 92) (26 to 55) (0.40 to 0.68)
50% VO2 reserve 75 85 30 0.56
  (65 to 96) (17 to 45) (0.42 to 0.70)
ACSM 2011 66 88 56 0.61
  (76 to 95) (26 to 73) (0.45 to 0.76)
ACSM/AHA= current American College of Sports Medicine and American Heart Association recommendation (2007) [7]; ACSM/AHAo= American College of Sports Medicine
recommendation for older adults (2007) [6]; 50% VO2 reserve= individual cut-point corresponding to 50% of oxygen uptake reserve; ACSM 2011: age-dependent cut-points
from ACSM Position Stand 2011 [12]. MVPA= time spent in moderate to vigorous physical activities.
doi: 10.1371/journal.pone.0084365.t004
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62% male, 51% >30 minutes MVPA per day (bouts)) (Figure
2A) were 86% (57 to 98) and 83% (61 to 95), respectively.
Finally, this proposed MVPA non-bout cut-point (80 min*day-1)
was used to validate in a sample with COPD (n=113). Figure
2B demonstrated the balance of sensitivity and specificity of
this target in patients with COPD (98% sensitivity (95%CI, 89 to
100) and 58% specificity (95%CI, 45 to 70). Hence, the
likelihood ratio (sensitivity/[1-specificity]) in the healthy subjects
(cross-validation sample) and subjects with COPD was 5.1
[1.5-19.6] and 2.3 [1.6-3.3], respectively.
Discussion
This study showed that (i) the time spent in moderate to
vigorous physical activities (MVPA) was variable across
different physical activity guidelines with lowest values for age-
specific cut offs (ACSM 2011). Selecting a METs cut-point
corresponding to 50% of VO2 reserve revealed no differences
in MVPA between groups. A discrepancy was observed
between 1.7 PAL and 30 minutes of MVPA as a guide to
physical activity. A PAL of 1.7 corresponds to 57 minutes
MVPA (BOUTS) and classifies the majority (69%) of subjects
as inactive. Healthy subjects and particularly patients with
COPD spend less time in MVPA when only bouts of 10 minutes
were considered. (ii) The proposed MVPA non-bouts cut-point
of 80 min*day-1, using a 3 METs MVPA threshold, was
associated with the MVPA bouts cut-point of 30 min*day-1 in
subjects with and without COPD.
The reduction in MVPA by using the higher age-dependent
METs cut-points of the ACSM Position Stand (2011) or by
analyzing MVPA with bouts of at least 10 minutes can lead to
confusion in assessing the physical activity status. Our data
corroborate with those of Thompson et al. who concluded that
in a middle-aged cohort (45-64y) 90% of the subjects could be
variably described as either active or not sufficiently active,
depending on the physical activity recommendation for MVPA
that is applied [36]. In order to address this point, details of the
selected METs cut-points and type of data analysis (bouts or
non-bouts) should be provided in clinical trials, as advocated by
the recent guidance of the ACSM [37]. Our data can help to
convert non-bouts information to data with bouts of at least 10
minutes. The latter is becoming important since
accelerometers, which enable non-bouts information, are
increasingly used in assessing physical activity levels.
Additionally, the definition of a bout should be clearly stated.
We defined an MVPA bout as a consecutive period of at least
10 consecutive minutes above 3 METs. Two recent papers
used a different ‘MVPA bouts definition’ by taking an accepted
interruption period of 1 or 2 minutes below the threshold (3
METs) during a bout of at least 10 minutes [38] or by defining
an bout as a consecutive period of at least 10 minutes above 3
METs according to their median intensity [39]. Due to these
slight differences in ‘MVPA bouts definition’, it can be
speculated that it would not have an important impact on the
data interpretation, i.e. data-analysis in bouts will lead to
significantly lower amount of MVPA compared to non-bouts
analysis. However, the application of the MVPA bouts analysis
Figure 2.  (Cross- ) validation of the new proposed non-bouts cut-point.  ROC curve showing the sensitivity and specificity
percentages of the proposed MVPA non-bouts cut-point in the healthy cross-validation sample (n=37) (A) and in patients with
COPD (n=113) (B). The dotted line represents the ROC curve of the healthy calibration sample.
doi: 10.1371/journal.pone.0084365.g002
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should be further clarified in future research in order to set
standardized recommendations for this type of data analysis
[40].
To the best of our knowledge, this is the first study that used
a METs cut-point corresponding to 50% of subjects’ individual
VO2 reserve. No differences were found in MVPA between
healthy subjects and COPD when this relative cut-point was
applied for every subject. This result is counterintuitive and not
in line with the general observation of inactivity in patients with
COPD in the present data and others [41]. Patients with COPD
have a reduced maximal exercise capacity and hence a low
VO2 reserve compared to healthy controls. In subjects with
severely reduced exercise capacity (e.g. COPD) 50% of VO2
reserve may represent a very light intense physical activity in
absolute terms. This would lead to an overestimation in MVPA.
Caution is warranted when 50% of VO2 reserve is applied to
identify active patients in this population.
Another pitfall that needs consideration when classifying
subjects as physically (in-) active is the required target that has
been used. The daily target of 1.7 PAL and 30 minutes MVPA
(bouts) with age-dependent METs cut-points (ACSM 2011) will
classify the majority of subjects as physically inactive. The
general aims behind the different physical activity
recommendations are a possible explanation for this
discrepancy. ACSM/AHA aims to improve and maintain the
general health, where the ACSM position stand wants to
develop and maintain the physical fitness. Thus, an important
distinction has to be made between physical activities related
to health (ACSM/AHA(O)) versus fitness (ACSM 2011). The cut-
point of 1.7 PAL aims to prevent weight gain and has been
previously reported to correspond to 45 to 60 minutes MVPA
per day [9]. This is confirmed by our data, i.e. 57 minutes
MVPA in bouts or 122 minutes MVPA in non-bouts are
equivalent to 1.7 PAL. Therefore, 1.7 PAL is a very stringent
target to classify active subjects compared to the 30 minutes
MVPA (bouts) by ACSM/AHA(O). A limitation of the present
study was that part of the COPD patients (physical activity
counseling study) did not have activity monitoring data for the
recommended minimum of 22 hours per day to calculate PAL
[42]. The wearing time of these patients was 16.87 ± 4.48
hours per day. Hence, we predicted the resting energy
expenditure of these missing data (minutes) by the Harrison
and Benedict equations [28]. Resting energy expenditure
estimates of the SenseWear Pro 2 Armband and the Harrison
and Benedict equations are successfully validated against
indirect calorimetry [43,44]. Therefore, the average ~6 hours
difference (sleeping time) with the subjects from the
comorbidities study (23.08 ± 1.35 hours per day) probably
would not have an important impact on the energy expenditure
data.
The development and validation of a MVPA non-bouts cut-
point has, to our knowledge, never been performed. This
seemed useful since data analysis of MVPA in bouts of at least
10 minutes is not always performed by clinicians and
researchers which lead to seemingly discrepant results. In a
Swedish cohort of 1114 adults, 52% achieved the 30 minute
goal when analyzed without bouts compared to only 1% when
analyzed in bouts of at least 10 minutes [45]. The MVPA non-
bouts cut-point of 80 min*day-1 delivered positive likelihood
ratios of 5.1 [1.5-19.6] and 2.3 [1.6-3.3] in healthy subjects and
subjects with COPD, respectively. This indicates that the
proposed MVPA non-bout target of 80 min*day-1 is associated
with the commonly-used activity target of MVPA bout target of
30 min*day-1. The stronger association in healthy subjects
compared to subjects with COPD (as reflected by the higher
likelihood ratio) can be explained by the lower specificity value
in the subjects with COPD. The latter makes sense since our
data showed that the reduction in MVPA when using bouts
(compared to non-bouts) was more pronounced in patients with
COPD (table 3). The more preserved daily MVPA when
analyzed in non-bouts compared to bouts in COPD could be
analyzed by the false positive rate (i.e. type I error or 1-
specificity, which are the inactive subjects (<30 MVPA cut-point
per day (bouts) who are labeled as active according to the 80
minute MVPA non-bout target). Indeed, the false positive rate
was 42% compared to 17% in subjects with COPD compared
to healthy subjects, respectively. To make stronger statement
about this new MVPA non-bout target, future trials are needed
to further validate whether long-term health benefits are
obtained in subjects achieving these goals. Our study
population consisted of healthy subjects and a specific chronic
disease population (i.e. COPD). It might not be possible to
generalize our results to other chronic disease populations.
However the COPD subjects are representative in terms of
physical activity levels when compared to other chronic
diseases such as nefropathy [46], coronary heart disease [47]
and metabolic syndrome [48]. It also has not be noted that the
commonly-used recommendation of 30 minutes MVPA per day
is based on the survey assessment of the leisure time physical
activities by a physical activity questionnaire [49]. The objective
assessment of all physical activity domains (household,
occupational, leisure/recreation and active transport activities)
by activity monitors (minute-by-minute data) may assume that
this 30 minute recommendation would be higher when based
on activity monitor data. The latter is already confirmed by the
development and validation of the 80 minutes (non-bout)
target. Finally, it remains unclear whether these MVPA targets
are linked with adverse health-related outcomes, especially in
the COPD population. This emphasizes the importance to
validate the MVPA targets in future research. The present
study can guide researchers and clinicians in collecting,
analyzing and interpreting data of MVPA that are collected
without bouts by accelerometers. This is worthwhile since the
use of MVPA as a physical activity estimate as well as the
transparency in collection and analysis of these data are
strongly recommended [37].
In conclusion, the present study showed that MVPA varies
depending on the selected PA guideline/targets and bouts
versus non-bouts analysis. Accelerometry measured MVPA
non-bouts target of 80 min*day-1, using a 3 METs MVPA
threshold, is associated to the commonly-used MVPA bout
target of 30 min*day-1.
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